Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,210 total articles
PN Smart Energy Limited (NASDAQ: PN) announced that its subsidiary, Nanjing Cesun Power Development, has signed a framework agreement to acquire six rooftop solar projects totaling 9.9 MW in Ningbo, Zhejiang Province from Zhejiang Yuntan Technology. The acquisition, valued at approximately $4.45 million, is a key step in PN Smart's strategic transi…
Founder Group Limited has signed a RM5.58 million (US$1.37 million) contract to build a 1.78 MW rooftop solar system for a shrimp farming and processing facility in Kedah, Malaysia. This marks the company's second major aquaculture-focused renewable energy project, supporting Malaysia's growing aquaculture sector and national renewable energy goals…
Aprea Therapeutics reported Q2 2026 financial results and provided updates on its clinical-stage oncology programs. Enrollment in the Phase 1 ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating with expansion to more clinical sites. Early data show promising anti-tumor activity and manageable tolerability. The company plans to advance…
Exyn Technologies announced the formation of a Defense Advisory Board to enhance its efforts in securing and scaling autonomous technology programs with the U.S. and allied defense sectors. Andrew Knaggs, a former Deputy Assistant Secretary of Defense and decorated Green Beret, has been named the inaugural member. This move supports Exyn's recent g…
Propanc Biopharma highlights its lead candidate PRP, a novel proenzyme therapy aiming to treat aggressive, treatment-resistant RAS-driven cancers by promoting cancer cell differentiation and reversing metastatic processes. PRP differs from current RAS inhibitors by targeting cancer stem cells and epithelial-mesenchymal transition rather than solely…
Cloudastructure, Inc., a NASDAQ-listed AI surveillance and security analytics company, has been awarded the installation contract for a third multifamily property with a longtime Baltimore developer. The initial phase includes installing approximately 70 cameras, with advanced AI surveillance and remote guarding services expected to be utilized aft…
Dyadic International, Inc. reported its Q2 2026 financial results showing continued commercialization progress across recombinant proteins and strategic OEM partnerships. The company advanced multiple product shipments, scale-up agreements, and global health initiatives using its proprietary C1 biomanufacturing platform. Despite increased costs and…
Powerus, through its subsidiary Tandem Defense, received a $2.51 million purchase order from a Department of War prime contractor for 1,500 U.S.-made FPV drones, pilot kits, and spare parts. The drones are manufactured domestically, compliant with NDAA and TAA, and delivery is expected within 60 days. The announcement coincides with Aureus Greenway…
Alico, Inc., a Florida-based agribusiness and land management company, announced that its CEO will present at the 17th Annual Midwest IDEAS Investor Conference. The presentation will highlight Alico's strategic transformation and diversified land operations across 47,300 acres in Florida following its 2025 restructuring. The company aims to leverag…
Bath & Body Works, Inc. (NYSE: BBWI) announced that it will report its financial results for the second quarter of 2026 before the market opens on August 26, 2026. The company will also host a conference call featuring CEO Daniel Heaf and interim CFO Tom Javitch to discuss the results and provide a business update. Supplemental materials will be av…
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, announced that the Japanese Patent Office has granted a patent covering NeuroThera's proprietary pharmacological combination involving 4-aminophenol derivatives and N-acylethanolamines. The patent protects formulations aimed at enhancing the analgesic and antipyretic effects of 4…
Autonomix Medical, Inc. announced the successful completion of its Good Laboratory Practice (GLP) preclinical study, demonstrating positive safety and performance outcomes for its nerve-targeted treatment platform. This milestone supports upcoming FDA submission efforts and marks significant progress in the company’s development of innovative medic…
Scienture Holdings announces the commercial launch and initial order fulfillment of REZENOPY™, a 10 mg naloxone hydrochloride nasal spray, targeting the $143 million U.S. naloxone market. The product is backed by national sales efforts, payer coverage for 100 million lives, and access to over 5,000 healthcare facilities, aiming to expand institutio…
Safe Pro Group Inc. has entered a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Engineer Research and Development Center to jointly develop AI-powered image analysis technologies leveraging uncrewed aerial systems. The partnership aims to enhance situational awareness solutions for military and civil uses, focusing on th…
Antalpha Platform Holding Company, a Nasdaq-listed fintech firm specializing in digital asset financing for the Web3 industry, announced it will release its Q2 2026 financial results on August 19, 2026, prior to the market open. The management team will host a conference call to discuss the results and address investor questions.
Binah Capital Group, a NASDAQ-listed financial services company, announced its participation in the Sidoti Micro-Cap Virtual Conference scheduled for August 19-20, 2026. The company's CEO and CFO will present on August 20, sharing insights into Binah's hybrid-friendly platform that supports independent financial advisors (RIAs). The event webcast w…
Tvardi Therapeutics, a clinical-stage biopharmaceutical company listed on NASDAQ under the ticker TVRD, will host a webinar featuring Dr. Randy Longman to discuss the evolving treatment landscape of ulcerative colitis (UC) and new data on their investigational oral small molecule drug TTI-109 targeting STAT3. The Phase 1 healthy volunteer results s…
Agencia Comercial Spirits Ltd, listed on NASDAQ, announced that its subsidiary has entered into a five-year technical services agreement worth $10 million with a regional provider to support networking integration for its AI computing infrastructure deployment in Indonesia. This initiative is a co-primary business alongside its established premium …
PodcastOne reported record first quarter fiscal 2027 revenue of $16.1 million, an 8% year-over-year increase, alongside an adjusted EBITDA of $1.6 million, up 172% from the prior year. The company expanded its creator portfolio and strengthened its market position by achieving its highest-ever Podtrac ranking (#6), surpassing major competitors incl…
Century Therapeutics reported strong Q2 2026 results highlighting significant progress in its iPSC-derived cell therapy pipeline, including a positive pre-IND meeting with the FDA for CNTY-813 targeting type 1 diabetes functional cure and ongoing preparations for CNTY-308 clinical trials in B-cell diseases. The company established Phase 1 manufactu…
High Roller Technologies, Inc., a publicly traded company on the NYSE, appoints Thomas Scaria, CFA, as its first Chief Product Officer to spearhead the development and launch of its ROLR prediction markets platform. The new role reflects the company's strategic focus on accelerating product innovation and market expansion in the real-money online g…
Avalyn Pharma announced the completion of patient enrollment for its global Phase 2b MIST trial evaluating AP01 for progressive pulmonary fibrosis. The trial overenrolled with 398 patients, and topline data are expected in late 2027. The company is also progressing Phase 2 AURA trial for AP02 and plans to initiate Phase 1 for AP03 by end of 2026. A…
LiqTech International, Inc. announced its second quarter 2026 financial results, reporting a decline in revenue to $4.4 million and net loss of $3.1 million. The company revised its full-year 2026 revenue guidance to $20-23 million, reflecting delays in a major Water for Energy project. LiqTech highlighted strong growth in Commercial Pool and Marin…
NeOnc Technologies announced encouraging topline results from its Phase 2a study of intranasal NEO100 in patients with recurrent IDH1-mutant high-grade glioma. The study met its primary endpoint, with a six-month progression-free survival rate of 48.9%, significantly exceeding the 20% benchmark. Median overall survival was 26.09 months, with no maj…
Solana Company (NASDAQ: HSDT), a digital asset treasury and infrastructure firm focusing on the Solana ecosystem, announced it will release its second quarter 2026 operating results on August 14, 2026, followed by a management conference call to discuss the results and provide a business update.
